These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29701141)

  • 41. Discovery of N-(2-aminoethyl)-N-benzyloxyphenyl benzamides: New potent Trypanosoma brucei inhibitors.
    Buchynskyy A; Gillespie JR; Hulverson MA; McQueen J; Creason SA; Ranade RM; Duster NA; Gelb MH; Buckner FS
    Bioorg Med Chem; 2017 Mar; 25(5):1571-1584. PubMed ID: 28187957
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug discovery for human African trypanosomiasis: identification of novel scaffolds by the newly developed HTS SYBR Green assay for Trypanosoma brucei.
    Faria J; Moraes CB; Song R; Pascoalino BS; Lee N; Siqueira-Neto JL; Cruz DJ; Parkinson T; Ioset JR; Cordeiro-da-Silva A; Freitas-Junior LH
    J Biomol Screen; 2015 Jan; 20(1):70-81. PubMed ID: 25342146
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structures of Trypanosoma brucei methionyl-tRNA synthetase with urea-based inhibitors provide guidance for drug design against sleeping sickness.
    Koh CY; Kim JE; Wetzel AB; de van der Schueren WJ; Shibata S; Ranade RM; Liu J; Zhang Z; Gillespie JR; Buckner FS; Verlinde CL; Fan E; Hol WG
    PLoS Negl Trop Dis; 2014 Apr; 8(4):e2775. PubMed ID: 24743796
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of lysine acetylation on the regulation of Trypanosoma brucei glycosomal aldolase activity.
    Barbosa Leite A; Severo Gomes AA; de Castro Nascimento Sousa AC; Roberto de Mattos Fontes M; Schenkman S; Silvio Moretti N
    Biochem J; 2020 May; 477(9):1733-1744. PubMed ID: 32329788
    [TBL] [Abstract][Full Text] [Related]  

  • 45. First small molecular inhibitors of T. brucei dolicholphosphate mannose synthase (DPMS), a validated drug target in African sleeping sickness.
    Smith TK; Young BL; Denton H; Hughes DL; Wagner GK
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1749-52. PubMed ID: 19217283
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Screening North American plant extracts in vitro against Trypanosoma brucei for discovery of new antitrypanosomal drug leads.
    Jain S; Jacob M; Walker L; Tekwani B
    BMC Complement Altern Med; 2016 May; 16():131. PubMed ID: 27193901
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Screening a random pentapeptide library, composed of 14 D-amino acids, against the COOH-terminal sequence of fructose-1,6-bisphosphate aldolase from Trypanosoma brucei.
    Samson I; Rozenski J; Samyn B; Van Aerschot A; Van Beeumen J; Herdewijn P
    J Biol Chem; 1997 Apr; 272(17):11378-83. PubMed ID: 9111046
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of novel drugs for human African trypanosomiasis.
    Brun R; Don R; Jacobs RT; Wang MZ; Barrett MP
    Future Microbiol; 2011 Jun; 6(6):677-91. PubMed ID: 21707314
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Crystal structures and inhibition of Trypanosoma brucei hypoxanthine-guanine phosphoribosyltransferase.
    Terán D; Hocková D; Česnek M; Zíková A; Naesens L; Keough DT; Guddat LW
    Sci Rep; 2016 Oct; 6():35894. PubMed ID: 27786284
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trypanosoma brucei glycogen synthase kinase-3, a target for anti-trypanosomal drug development: a public-private partnership to identify novel leads.
    Oduor RO; Ojo KK; Williams GP; Bertelli F; Mills J; Maes L; Pryde DC; Parkinson T; Van Voorhis WC; Holler TP
    PLoS Negl Trop Dis; 2011 Apr; 5(4):e1017. PubMed ID: 21483717
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Editorial: Drug Discovery for Neglected Diseases.
    Andricopulo AD; Ferreira LLG
    Curr Top Med Chem; 2018; 18(5):313-314. PubMed ID: 29968533
    [No Abstract]   [Full Text] [Related]  

  • 52. Optimization of a binding fragment targeting the "enlarged methionine pocket" leads to potent Trypanosoma brucei methionyl-tRNA synthetase inhibitors.
    Huang W; Zhang Z; Ranade RM; Gillespie JR; Barros-Álvarez X; Creason SA; Shibata S; Verlinde CLMJ; Hol WGJ; Buckner FS; Fan E
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2702-2707. PubMed ID: 28465105
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent.
    Yang PY; Wang M; Liu K; Ngai MH; Sheriff O; Lear MJ; Sze SK; He CY; Yao SQ
    Chemistry; 2012 Jul; 18(27):8403-13. PubMed ID: 22674877
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Designing sleeping sickness control.
    Kinoshita T
    ACS Chem Biol; 2008 Oct; 3(10):601-3. PubMed ID: 18928247
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ethyl Pyruvate Emerges as a Safe and Fast Acting Agent against Trypanosoma brucei by Targeting Pyruvate Kinase Activity.
    Worku N; Stich A; Daugschies A; Wenzel I; Kurz R; Thieme R; Kurz S; Birkenmeier G
    PLoS One; 2015; 10(9):e0137353. PubMed ID: 26340747
    [TBL] [Abstract][Full Text] [Related]  

  • 56. QSAR analysis for 6-arylpyrazine-2-carboxamides as Trypanosoma brucei inhibitors.
    Masand VH; El-Sayed NN; Mahajan DT; Rastija V
    SAR QSAR Environ Res; 2017 Feb; 28(2):165-177. PubMed ID: 28235390
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery of N-(4-sulfamoylphenyl)thioureas as Trypanosoma brucei leucyl-tRNA synthetase inhibitors.
    Zhang F; Du J; Wang Q; Hu Q; Zhang J; Ding D; Zhao Y; Yang F; Wang E; Zhou H
    Org Biomol Chem; 2013 Aug; 11(32):5310-24. PubMed ID: 23842857
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structures of purine nucleosidase from Trypanosoma brucei bound to isozyme-specific trypanocidals and a novel metalorganic inhibitor.
    Giannese F; Berg M; Van der Veken P; Castagna V; Tornaghi P; Augustyns K; Degano M
    Acta Crystallogr D Biol Crystallogr; 2013 Aug; 69(Pt 8):1553-66. PubMed ID: 23897478
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the Trypanosoma brucei 6-oxopurine salvage pathway as a potential target for drug discovery.
    Doleželová E; Terán D; Gahura O; Kotrbová Z; Procházková M; Keough D; Špaček P; Hocková D; Guddat L; Zíková A
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006301. PubMed ID: 29481567
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discovery of novel Trypanosoma brucei phosphodiesterase B1 inhibitors by virtual screening against the unliganded TbrPDEB1 crystal structure.
    Jansen C; Wang H; Kooistra AJ; de Graaf C; Orrling KM; Tenor H; Seebeck T; Bailey D; de Esch IJ; Ke H; Leurs R
    J Med Chem; 2013 Mar; 56(5):2087-96. PubMed ID: 23409953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.